BiomX
Founded
2015
2015
Geography
Israel based
Israel based
Funding
$56 M
$56 M
BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators: Professor Rotem Sorek, PhD and Dr. Eran Elinav, MD, PhD both of the Weizmann Institute of Science and Professor Timothy K. Lu, MD, PhD of the Massachusetts Institute of Technology.
Technologies
Microbiome StartupsPosts Mentioning This Company
R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet